In addition, the surface glycoprotein CD44 and oncogene BMI1 have been identified as key markers of the CSC subpopulation in breast cancer and head and neck squamous cell carcinoma (HNSCC) [5]. The gene discussed is BMI1; the disease is head and neck squamous cell carcinoma.